Launched publicly today, and funded with $50M at this point, Corsera Health hopes to target those who are most at risk for atherosclerotic cardiovascular disease from an early age. The goal is to extend lives with an annual medicine by lowering LDL and blood pressure.
View all episodes
By BiotechTV
5
44 ratings
Launched publicly today, and funded with $50M at this point, Corsera Health hopes to target those who are most at risk for atherosclerotic cardiovascular disease from an early age. The goal is to extend lives with an annual medicine by lowering LDL and blood pressure.
30,642 Listeners
1,874 Listeners
1,087 Listeners
325 Listeners
6,092 Listeners
60 Listeners
9,862 Listeners
86 Listeners
34 Listeners
19 Listeners
261 Listeners
504 Listeners
0 Listeners
4 Listeners
2 Listeners
6 Listeners